Dominant-Negative Mutation of p53 Tumor Suppressor Gene in Endometrial Carcinoma

By Sakuragi N.   Hirai A.   Tada M.   Yamada H.   Yamamoto R.   Fujimoto S.   Moriuchi T.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 485-490

Elsevier

Access to resources Recommend Favorite

Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 753-764

Science Publishers

Access to resources Recommend Favorite

Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations

By Havrilesky L.J.   Alvarez A.A.   Whitaker R.S.   Marks J.R.   Berchuck A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 491-500

Elsevier

Access to resources Recommend Favorite

Squamous Cell Carcinoma of the Endometrium with Human Papillomavirus Type 31 and without Tumor Suppressor Gene p53 Mutation

By Kataoka A.   Nishida T.   Sugiyama T.   Hori K.   Honda S.   Yakushiji M.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 180-184

Elsevier

Access to resources Recommend Favorite

Screening of candidate tumor-suppressor genes in 3p21.3 and investigation of the methylation of gene promoters in oral squamous cell carcinoma

By        

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1175-1182

Spandidos Publications

Access to resources Recommend Favorite